These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39392159)

  • 1. Synthetic Antiangiogenic Vascular Endothelial Growth Factor-A Splice Variant Revascularizes Ischemic Muscle in Peripheral Artery Disease.
    Raja A; Ganta V
    J Am Heart Assoc; 2024 Oct; 13(20):e034304. PubMed ID: 39392159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic VEGF
    Ganta VC; Choi M; Farber CR; Annex BH
    Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
    Ganta VC; Choi M; Kutateladze A; Annex BH
    Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia.
    Imoukhuede PI; Dokun AO; Annex BH; Popel AS
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1085-93. PubMed ID: 23376830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Anti-Angiogenic VEGF
    Kuppuswamy S; Annex BH; Ganta VC
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems Pharmacology of VEGF165b in Peripheral Artery Disease.
    Clegg LE; Ganta VC; Annex BH; Mac Gabhann F
    CPT Pharmacometrics Syst Pharmacol; 2017 Dec; 6(12):833-844. PubMed ID: 29193887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF
    Chu LH; Ganta VC; Choi MH; Chen G; Finley SD; Annex BH; Popel AS
    Sci Rep; 2016 Nov; 6():37030. PubMed ID: 27853189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolytic PFKFB3 and Glycogenic UGP2 Axis Regulates Perfusion Recovery in Experimental Hind Limb Ischemia.
    Jaiyesimi O; Kuppuswamy S; Zhang G; Batan S; Zhi W; Ganta VC
    Arterioscler Thromb Vasc Biol; 2024 Aug; 44(8):1764-1783. PubMed ID: 38934117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting anti-angiogenic VEGF165b activates a miR-17-20a-Calcipressin-3 pathway that revascularizes ischemic muscle in peripheral artery disease.
    Batan S; Kuppuswamy S; Wood M; Reddy M; Annex B; Ganta V
    Commun Med (Lond); 2024 Jan; 4(1):3. PubMed ID: 38182796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia.
    Clayton JA; Chalothorn D; Faber JE
    Circ Res; 2008 Oct; 103(9):1027-36. PubMed ID: 18802023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting Anti-angiogenic VEGF165b Activates a Novel miR-17-20a-Calcipressin-3 Pathway that Revascularizes Ischemic Muscle in Peripheral Artery Disease.
    Batan S; Kuppuswamy S; Wood M; Reddy M; Annex BH; Ganta VC
    Res Sq; 2023 Aug; ():. PubMed ID: 37645966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective binding of C-6 OH sulfated hyaluronic acid to the angiogenic isoform of VEGF(165).
    Lim DK; Wylie RG; Langer R; Kohane DS
    Biomaterials; 2016 Jan; 77():130-138. PubMed ID: 26588795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
    Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells.
    Ourradi K; Blythe T; Jarrett C; Barratt SL; Welsh GI; Millar AB
    Respir Res; 2017 Jun; 18(1):116. PubMed ID: 28578669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGFR1 and VEGFR2 in Alzheimer's Disease.
    Harris R; Miners JS; Allen S; Love S
    J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral vascular disease: preclinical models and emerging therapeutic targeting of the vascular endothelial growth factor ligand-receptor system.
    Ganta VC; Annex BH
    Expert Opin Ther Targets; 2021 May; 25(5):381-391. PubMed ID: 34098826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.